课题基金 / 基金详情

Genome wide analysis of LXR binding - metabolic and epigenetic regulation in AD

Genome wide analysis of LXR binding - metabolic and epigenetic regulation in AD
LXR 结合的全基因组分析 - AD 中的代谢和表观遗传调控
批准号:
8850762
负责人:
ILIYA LEFTEROV
金额:
$46.08万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-09-01 至 2016-05-31
关键词:
Activities of Daily LivingAddressAgeAgonistAlzheimer&aposs DiseaseAmyloidBehaviorBehavioralBinding SitesBiochemicalBiochemical PathwayBrainCationsCholesterolChromatinComplexCoupledDNADataData SetDementiaDepositionDevelopmentDietDietary PracticesDiseaseDisease ProgressionDown-RegulationElderlyEnvironmental Risk FactorEpigenetic ProcessExposure toFatty acid glycerol estersFutureGene ProteinsGene TargetingGenerationsGenesGenomeGenotypeGoalsHealthHigh-Throughput Nucleotide SequencingHumanHyperinsulinismImpaired cognitionInflammatoryInsulin ResistanceKnowledgeLate Onset Alzheimer DiseaseLifeLife StyleLipoproteinsLiverLocationMassive Parallel SequencingMediatingMemory impairmentMetabolicMetabolic PathwayModificationMusNuclearNutritionalObesityOrganPathogenesisPathologyPathway AnalysisPatientsPeripheralPersonsPharmacological TreatmentPhenotypePhospholipidsPlayPredispositionProteinsReactionReceptor ActivationReportingReproductionResearchResolutionRiskRoleSignal TransductionSkin AgingStimulusTestingTherapeutic EffectTissuesTransgenic MiceUp-RegulationVariantage relatedbasechromatin immunoprecipitationchromatin modificationcognitive functioncognitive performancedisease phenotypeepigenetic regulationgene environment interactiongene functiongenome-widegenome-wide analysisglucose metabolismhistone modificationhypercholesterolemiain vivoinsulin secretionlipid metabolismlong term memorymiddle agemouse modelnovel therapeuticsreceptorreceptor bindingreceptor functionresearch studyresponsetraittranscription factor

项目摘要

项目成果

ILIYA LEFTEROV的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):阿尔茨海默病(AD)是最常见的痴呆症,在美国有超过550万患者,到2047年这一数字将翻两番。这种疾病的特征是认知功能的加速丧失,其程度严重干扰了一个人的日常生活和活动。阿尔茨海默病是一种复杂的性状,其易感性的数量变化受多种基因和环境因素的控制。重要的是,一些环境和代谢刺激,如高胆固醇血症、肥胖、高胰岛素血症和胰岛素抵抗,遵循一定的饮食模式和生活方式,只有在中年时面对,才会增加老年痴呆症和阿尔茨海默病的风险。在这方面,饮食药物的表观遗传重编程,改变组蛋白修饰并在整个生命中保留,应该被认为与阿尔茨海默病的发病机制高度相关,支持年龄依赖性基因-环境相互作用对晚发型阿尔茨海默病(LOAD)的发生和进展至关重要的观点。外周和中枢神经系统中胆固醇和磷脂转运的代谢途径,以及胰岛素分泌的一些限速步骤,都是由氧甾醇敏感转录因子核肝X受体(LXRs) - LXR1和LXR2通过其应答基因的表达水平控制的。我们假设,在AD的背景下,对高脂肪饮食(HFD)的反应是通过表观遗传染色质修饰和LXR与DNA结合介导的,并最终通过组织和器官选择性转录活性实现。本提案的目标主要有两个方面:目标1。利用第二代高通量测序来评估营养信号诱导的染色质修饰的变化及其在认知能力和AD病理的发展和进展中的作用。目标2。揭示HFD引起的LXR结合的全基因组变化,从而鉴定其转录上调或下调在模型小鼠ad样表型的发生和进展中起作用的LXR靶点。
英文摘要
DESCRIPTION (provided by applicant): Alzheimer's disease (AD) is the most common form of dementia with more than 5.5 million patients in the USA, a number that will quadruple by 2047. The disease can be characterized as an accelerated loss of cognitive functioning to such an extent that it interferes drastically with a person's daily life and activities. AD is a complex trait in that underlying quantitative variation in susceptibility is controlled by multiple genes and environmental factors. Importantly, some of these environmental and metabolic stimuli, like hypercholesterolemia, obesity, hyperinsulinemia and insulin resistance, which follow certain dietary patterns and lifestyle, are associated with increased risk of dementia and AD at advanced age, only if confronted in midlife. In this respect the epigenetic reprogramming by dietary agents, which change histone modifications and are retained throughout the life, should be considered highly relevant to AD pathogenesis, supporting the idea of age dependent gene-environment interactions as critical for the development and progression of late onset AD (LOAD). The metabolic pathways of cholesterol and phospholipid transport in the periphery and CNS, as well as some rate limiting steps of insulin secretion, are controlled by oxysterol-sensing transcription factors nuclear liver X receptors (LXRs) - LXR1 and LXR2, through the expression level of their responsive genes. We hypothesize that in the context of AD the response to high fat diet (HFD) is mediated by epigenetic chromatin modification and LXR binding to DNA and is ultimately realized by tissue and organ-selective transcriptional activity. The goal of this proposal has two major aspects: Aim 1. Using second generation high throughput sequencing to assess changes in chromatin modifications induced by nutritional signals and their role in the development and progression of cognitive performance and AD pathology. Aim 2. To reveal genome-wide changes in LXR binding caused by HFD and thus to identify LXR targets whose transcriptional up- or down-regulation has a role in the development and progression of AD-like phenotype in model mice.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Genome Wide Analysis LXR Binding-Metabolic and Epigenetic Regulation in AD
Genome wide analysis of LXR binding - metabolic and epigenetic regulation in AD
Genome wide analysis of LXR binding - metabolic and epigenetic regulation in AD
Genome wide analysis of LXR binding - metabolic and epigenetic regulation in AD
海外基金